MetLife Investment Management’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $260K | Buy |
|
|||||
|
2025
Q1 | $171K | Sell |
|
|||||
|
2024
Q4 | $306K | Buy |
|
|||||
|
2024
Q3 | $408K | Hold |
|
|||||
|
2024
Q2 | $376K | Buy |
|
|||||
|
2024
Q1 | $382K | Hold |
|
|||||
|
2023
Q4 | $507K | Hold |
|
|||||
|
2023
Q3 | $387K | Hold |
|
|||||
|
2023
Q2 | $578K | Buy |
|
|||||
|
2023
Q1 | $735K | Hold |
|
|||||
|
2022
Q4 | $667K | Buy |
|
|||||
|
2022
Q3 | $913K | Buy |
|
|||||
|
2022
Q2 | $636K | Hold |
|
|||||
|
2022
Q1 | $1.14M | Buy |
|
|||||
|
2021
Q4 | $750K | Buy |
|
|||||
|
2021
Q3 | $671K | Hold |
|
|||||
|
2021
Q2 | $778K | Buy |
|
|||||
|
2021
Q1 | $607K | Buy |
|
|||||
|
2020
Q4 | $571K | Hold |
|
|||||
|
2020
Q3 | $585K | Buy |
|